[1] PARLAKPINAR H, GUNATA M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs[J].Immunopharmacol Immunotoxicol, 2021, 43(6):651
[2] KALT DA. Tacrolimus: a review of laboratory detection methods and indications for use[J].Lab Med, 2017, 48(4):e62
[3] ZAKARIA R, ALLEN KJ, KOPLIN JJ, et al. Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process[J].EJIFCC, 2016, 27(4):288
[4] GUTHRIE R, SUSI A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants[J].Pediatrics, 1963, 32: 338
[5] ENDERLE Y, FOERSTER K, BURHENNE J. Clinical feasibility of dried blood spots: analytics, validation, and applications[J].J Pharm Biomed Anal, 2016, 130: 231
[6] WILHELM AJ, DEN BURGER JC, SWART EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions[J].Clin Pharmacokinet, 2014, 53(11):961
[7] 程晓亮. 干血斑法在血药浓度监测中的应用[C]//第八届全国治疗药物监测学术年会. 郑州, 2018
CHENG XL. Application of dried blood spots in therapeutic drug monitoring[C]// The 8th national annual conference on therapeutic drug monitoring. Zhengzhou, 2018
[8] KLAK A, PAUWELS S, VERMEERSCH P. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots[J].Diagnosis(Berl), 2019, 6(1):57
[9] CAPIAU S, VEENHOF H, KOSTER RA, et al. Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring[J].Ther Drug Monit, 2019, 41(4):409
[10] WAGNER M, TONOLI D, VARESIO E, et al. The use of mass spectrometry to analyze dried blood spots[J].Mass Spectrom Rev, 2016, 35(3):361
[11] KOSTER RA, ALFFENAAR JW, BOTMA R, et al. The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis[J].Bioanalysis, 2015, 7(14):1717
[12] KOSTER RA, BOTMA R, GREIJDANUS B, et al. The performance of five different dried blood spot cards for the analysis of six immunosuppressants[J].Bioanalysis, 2015, 7(10):1225
[13] LEI B, PROW TW. A review of microsampling techniques and their social impact[J].Biomed Microdevices, 2019, 21(4):81
[14] VEENHOF H, KOSTER RA, ALFFENAAR JC, et al. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients[J].Clin Chem Lab Med, 2019, 57(12):1854
[15] ZWART TC, GOKOEL SRM, VAN DER BOOG PJM, et al. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device[J].Br J Clin Pharmacol, 2018, 84(12):2889
[16] BRESSÁN IG, GIMÉNEZ MI, LLESUY SF. Validation of a simple liquid chromatography coupled to tandem mass spectrometry method for the simultaneous determination of tacrolimus, sirolimus, everolimus and cyclosporin A in dried matrix on paper discs[J].J Mass Spectrom Adv Clin Lab, 2021, 19: 7
[17] CAPIAU S, STOVE VV, LAMBERT WE, et al. Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer[J].Anal Chem, 2013, 85(1):404
[18] ZIMMERMANN S, AGHAI F, SCHILLING B, et al. Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio[J].J Pharm Biomed Anal, 2022, 211: 114623
[19] TRON C, FERRAND-SORRE MJ, QUERZERHO-RAGUIDEAU J, et al. Volumetric absorptive microsampling for the quantification of tacrolimus in capillary blood by high performance liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2021, 1165: 122521
[20] VEENHOF H, KOSTER RA, JUNIER L, et al. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring[J].Clin Chem Lab Med, 2020, 58(10):1687
[21] PANIAGUA-GONZÁLEZ L, LENDOIRO E, OTERO-ANTÓN E, et al. Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination[J].J Pharm Biomed Anal, 2022, 208: 114443
[22] LEUTHOLD LA, HEUDI O, DÉGLON J, et al. New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis[J].Anal Chem, 2015, 87(4):2068
[23] AL-UZRI A, FREEMAN K A, WADE J, et al. Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation[J].Pediatr Transplant, 2017, 21(6):e12983
[24] MARTIAL LC, HOOGTANDERS K, SCHREUDER MF, et al. Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation[J].Ther Drug Monit, 2017, 39(4):412
[25] VEENHOF H, VAN BOVEN JFM, VAN DER VOORT A, et al. Effects, costs and implementation of monitoring kidney transplant patients' tacrolimus levels with dried blood spot sampling: a randomized controlled hybrid implementation trial[J].Br J Clin Pharmacol, 2020, 86(7):1357
[26] MCCLENDON-WEARY B, PUTNICK DL, ROBINSON S, et al. Little to give, much to gain-what can you do with a dried blood spot?[J].Curr Environ Health Rep, 2020, 7(3):211
[27] KOSTER RA, ALFFENAAR JW, GREIJDANUS B, et al. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin a in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery[J].Talanta, 2013, 115: 47
[28] VEENHOF H, KOSTER RA, ALFFENAAR JC, et al. Clinical validation of simultaneous analysis of tacrolimus, cyclosporine A, and creatinine in dried blood spots in kidney transplant patients[J].Transplantation, 2017, 101(7):1727
[29] HINCHLIFFE E, ADAWAY J, FILDES J, et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots[J].Ann Clin Biochem, 2014, 51(Pt 1):106
[30] HINCHLIFFE E, ADAWAY JE, KEEVIL BG. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 883-884: 102
[31] ARPINI J, ANTUNES MV, PACHECO LS, et al. Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients[J].Clin Biochem, 2013, 46(18):1905
[32] WILHELM AJ, den BURGER JC, VOS RM, et al. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2009,877(14-15):1595
[33] WILHELM A J, KLIJN A, den BURGER JC, et al. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling[J].Ther Drug Monit, 2013, 35(1):92
[34] KOOP DR, BLEYLE LA, MUNAR M, et al. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2013, 926: 54
[35] DICKERSON JA, SINKEY M, JACOT K, et al. Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring[J].Pediatr Transplant, 2015, 19(1):101
[36] SADILKOVA K, BUSBY B, DICKERSON JA, et al. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS[J].Clin Chim Acta, 2013,421: 152
[37] HOOGTANDERS K, VAN DER HEIJDEN J, CHRISTIAANS M, et al. Therapeutic drug monitoring of tacrolimus with the dried blood spot method[J].J Pharm Biomed Anal, 2007, 44(3):658
[38] IBOSHI H, YAMAGUCHI H, SUZUKI H, et al. Development of a liquid chromatography-tandem mass spectrometric method for quantification of mycophenolic acid and its glucuronides in dried blood spot samples[J].Ther Drug Monit, 2017, 39(6):648
[39] IACUZZI V, POSOCCO B, ZANCHETTA M, et al. Dried blood spot technique applied in therapeutic drug monitoring of anticancer drugs: a review on conversion methods to correlate plasma and dried blood spot concentrations[J].Pharm Res, 2021, 38(5):759
[40] MARTIAL LC, BIEWENGA M, RUIJTER BN, et al. Population pharmacokinetics and genetics of oral meltdose tacrolimus (envarsus) in stable adult liver transplant recipients[J].Br J Clin Pharmacol, 2021, 87(11):4262
[41] STIFFT F, STOLK LM, UNDRE N, et al. Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation[J].Transplantation, 2014, 97(7):775
[42] van BOEKEL GA, AARNOUTSE RE, HOOGTANDERS KE, et al. Delayed trough level measurement with the use of prolonged-release tacrolimus[J].Transpl Int, 2015,28(3):314
[43] ALMARDINI R, TAYBEH EO, ALSOUS MM, et al. A multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant[J].Br J Clin Pharmacol, 2019, 85(7):1434
[44] CHEUNG CY, VAN DER HEIJDEN J, HOOGTANDERS K, et al. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation[J].Transpl Int, 2008, 21(2):140
[45] VAN BOEKEL GA, DONDERS AR, HOOGTANDERS KE, et al. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique[J].Eur J Clin Pharmacol, 2015, 71(7):811
[46] LEINO AD, KING EC, JIANG W, et al. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values[J].Am J Transplant, 2019, 19(5):1410
